7 completed, 2 unknown. 2 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow SPP Pharmaclon Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis Interferon-Gamma - Respiratory Tuberculosis | Unknown | SPP Pharmaclon Ltd. | 350 | 2022-06-01 | 2023-11-09 | |
| Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis Interferon-Gamma - Pulmonary Tuberculosis | Unknown | SPP Pharmaclon Ltd. | 84 | 2022-04-15 | 2022-06-01 | |
| Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19 Interferon gamma human recombinant (IFN-G) - COVID-19 Respiratory Infection, Acute Respiratory Disease | Not applicable | Completed | SPP Pharmaclon Ltd. | 630 | 2020-12-21 | 2024-08-09 |
| Study of the Use of the Ingaron in Volunteers for the Prevention of COVID-19 Interferon gamma human recombinant (IFN-G) - COVID-19 Respiratory Infection | Completed | SPP Pharmaclon Ltd. | 100 | 2020-04-23 | 2022-05-23 | |
| Study of the Use of the Drug Ingaron in Patients With COVID-19 Interferon Gamma - COVID-19 Respiratory Infection, Viral Pneumonia | Completed | SPP Pharmaclon Ltd. | 36 | 2020-04-21 | 2022-05-27 | |
| Study of Ingaron's Effect on Efficacy and Resistance to Antibiotics in Community-acquired Pneumonia Interferon-Gamma - Community-acquired Pneumonia | Not applicable | Completed | SPP Pharmaclon Ltd. | 114 | 2017-05-12 | 2022-05-27 |
| Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts Interferon gamma human recombinant (IFN-G) - Human Papillomavirus Infection, Anogenital Warts | Phase 3 | Completed | SPP Pharmaclon Ltd. | 30 | 2009-05-18 | 2021-12-14 |
| Efficiency and Safety of the Drug Ingaron (Interferon-gamma Human Recombinant) in the Treatment of Chronic Prostatitis Interferon gamma human recombinant (IFN-G) - Chronic Prostatitis | Phase 3 | Completed | SPP Pharmaclon Ltd. | 30 | 2009-01-29 | 2022-05-18 |
| Study of Interferon-Gamma in the Complex Treatment of Patients Infected With HIV and Tuberculosis Interferon-Gamma - HIV Coinfection, Aids/Hiv Problem | Phase 1 / Phase 2 | Completed | SPP Pharmaclon Ltd. | 78 | 2006-01-19 | 2024-01-25 |
Tuberculosis, Pulmonary (3) · Acquired Immunodeficiency Syndrome (1) · Community-Acquired Pneumonia (1) · Condylomata Acuminata (1) · HIV Infections (1) · Lentivirus Infections (1) · Papillomavirus Infections (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Tuberculosis (1)
Interferon-gamma (5)
Russia (8)
Anatoly I Saulin, Master (6) · Leonid Apanansky, Master (2) · Vladimir Shmelev, Doctor (1)